FIELD: chemistry.
SUBSTANCE: group of inventions relates to new biologically active compounds – hybrid systems based on furan-2(3H)-one and chromene-4(4H)-thione of formula
,
where R1=H, R2=H (1), or R1=Cl, R2=H (2), or R1=CH3, R2=H (3), or R1=CH3, R2=CH3 (4), or R1=OCH3, R2=H (5), as well as a method of producing said compounds having antibacterial action, namely antibacterial activity on Escherichia coli K-12 cell culture, and is intended for use in medicine as an antibacterial agent.
EFFECT: obtaining hybrid compounds having high antibacterial action.
2 cl, 6 dwg, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PREPARING QUATERNISED USNIC ACID DERIVATIVES AND THEIR BIOLOGICAL PROPERTIES | 2012 |
|
RU2477127C1 |
3,3'[(HEXANO-1,6-DIYLBIS (AZANEDIYL)]BIS-(7-HYDROXY-6-METHOXYCARBONYL-2-OXO-2H-CHROMENE) WITH ANTIBACTERIAL ACTIVITY | 2021 |
|
RU2764522C1 |
APPLICATION OF A TRICYCLIC SULPHUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2 | 2021 |
|
RU2780247C1 |
ANTISEPTIC DRUG | 2017 |
|
RU2641309C1 |
N,N'-BIS(3-AMINOPROPYL)BUTANE-1,4-DIAMINO DERIVATIVES OF FUSIDIC ACID, HAVING A WIDE SPECTRUM OF ANTIMICROBIAL ACTIVITY | 2019 |
|
RU2726196C1 |
METHOD OF PRODUCING A TRICYCLIC SULFUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING REPLICATION OF BETA-CORONAVIRUSES, INCLUDING SARS-CoV-2 | 2021 |
|
RU2819783C1 |
PHARMACEUTICAL COMPOSITION, INCLUDING TRICYCLIC SULFUR-CONTAINING 1,2-DIHYDROQUINOLINE DERIVATIVE FOR INHIBITION OF REPLICATION OF BETA CORONAVIRUSES, INCLUDING SARS-CoV-2, AND METHOD OF ITS USE | 2021 |
|
RU2814434C1 |
(1-BENZYL-1H-1,2,3-TRIAZOL-4-YL)METHYL (Z)-2-((3S,4S,8S,10S,11R,14S,16S)-16-ACETOXY-3,11 -DIHYDROXY-4,8,10,14-TETRAMETHYLHEXADECAHYDRO-17H-CYCLOPENTA[a]PHENANTHRENE-17-YLIDENE)-6-METHYLHEPT-5-ENOATE EXHIBITING ANTIBACTERIAL AND FUNGICIDAL ACTIVITY | 2022 |
|
RU2784215C1 |
5-SUBSTITUTED 5-TRICHLOROACETYL-2-PHENYL-4H-1,3-DIOXIN-4-ONES, HAVING ANTIMICROBIAL ACTIVITY | 2023 |
|
RU2817115C1 |
PROP-2-IN-1-IL-(2Z)-2-[(3-alpha, 4-alpha, 8-alpha, 11-alpha, 14-beta, 16-beta)-16-(ACETYLOXY)-3.11-DIHYDROXY-4,8,10,14-TETRAMETHYLGONANE-17-YLIDENE]-6-METHYLHEPT-5-ENOATE, PREPARATION METHOD AND ANTIMICROBIAL PROPERTIES | 2021 |
|
RU2780014C1 |
Authors
Dates
2024-11-14—Published
2024-04-03—Filed